NAPHTH(2,3-C)ACRIDINE-5,8,14(13H)-TRIONE, 6-((4,6-BIS((9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-10-BROMO-
UNII HS3TW93K85

Substance Identification & Data

This profile provides standardized clinical and technical data for Naphth(2,3-c)acridine-5,8,14(13h)-trione, 6-((4,6-bis((9,10-dihydro-9,10-dioxo-1-anthracenyl)amino)-1,3,5-triazin-2-yl)amino)-10-bromo-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HS3TW93K85.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 83950-11-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
HS3TW93K85
CAS Registry Number
83950-11-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NAPHTH(2,3-C)ACRIDINE-5,8,14(13H)-TRIONE, 6-((4,6-BIS((9,10-DIHYDRO-9,10-DIOXO-1-ANTHRACENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-10-BROMO-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C52H26BrN7O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
LHPYJXQUACOTLP-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
Naphth[2,3-c]acridine-5,8,14(13H)-trione, 6-[[4,6-bis[(9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-1,3,5-triazin-2-yl]amino]-10-bromo-
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(c2c(c3[nH]c4ccc(cc4c(c31)=O)Br)C(c5ccccc5C2=O)=O)Nc6nc(nc(n6)Nc7cccc8C(c9ccccc9C(c87)=O)=O)Nc%10cccc%11C(c%12ccccc%12C(c%11%10)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naphth(2,3-c)acridine-5,8,14(13h)-trione, 6-((4,6-bis((9,10-dihydro-9,10-dioxo-1-anthracenyl)amino)-1,3,5-triazin-2-yl)amino)-10-bromo-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

6-[[4,6-Bis[(9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-1,3,5-triazin-2-yl]amino]-10-bromonaphth[2,3-c]acridine-5,8,14(13H)-trione
Naphth[2,3-c]acridine-5,8,14(13H)-trione, 6-[[4,6-bis[(9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-1,3,5-triazin-2-yl]amino]-10-bromo-